The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exposure-response (E-R) analysis of efficacy of pegvorhyaluronidase alfa (PEGPH20) in combination with nab-paclitaxel + gemcitabine (AG) in patients (Pts) with metastatic pancreatic ductal adenocarcinoma.
 
Yong Liu
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
 
Andrea J. Bullock
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Medtronic
Consulting or Advisory Role - Bayer; Celgene; Exelixis; Halozyme; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Halozyme
 
Julie Passarell
Research Funding - Halozyme
 
Sebastien Bihorel
Research Funding - Roche (I)
Patents, Royalties, Other Intellectual Property - Novartis (Inst)
Other Relationship - Cognigen Corporation
 
Jill Fiedler-Kelly
Research Funding - Halozyme
 
Thomas C Heineman
Employment - Genocea Biosciences; Halozyme
Stock and Other Ownership Interests - Genocea Biosciences; Halozyme
Consulting or Advisory Role - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Rose E. Sekulovich
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
Patents, Royalties, Other Intellectual Property - Halozyme